BMRN FY 2015 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena

BMRNBioMarin Pharmaceutical Inc.

$12B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$890M+18.8% YoY

Gross Profit

$738M82.9% margin

Operating Income

-$111M-12.4% margin

Net Income

-$172M-19.3% margin

EPS (Diluted)

$-1.07

Cash Flow

Operating Cash Flow

-$222M

Free Cash Flow

-$449M

Stock-Based Comp.

$112M

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$1.3B

Stockholders' Equity

$2.4B

Cash & Equivalents

$397M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$890M	$749M	+18.8%
Gross Profit	$738M	$627M	+17.7%
Operating Income	-$111M	-$93M	-19.2%
Net Income	-$172M	-$134M	-28.2%